BioPharma Dive September 10, 2024
The fund is Bain’s fourth and follows several recent acquisitions of some of its portfolio companies, among them Jnana Therapeutics and EyeBio.
Bain Capital Life Sciences said Tuesday it has secured about $3 billion for its fourth fund, bringing the private investment firm’s total haul since its 2016 inception to $6.7 billion.
Bain Capital said the new fund includes $2.5 billion of outside commitments from new and existing investors, with the remainder coming from its partners, employees and affiliates. The firm said it intends to use the cash to back companies working on therapeutics, medical devices, life science tools and diagnostics that will “improve the lives of patients with unmet medical needs.”
Since being formed eight years ago, Bain Capital’s...
Today's Sponsors
Today's Sponsor